Knorr-Bremse AG (KBX)
XETRA Stock Exchange · Germany · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 95.80 |
|---|---|
| 52-week range | 77.50 – 115.60 |
| Return, 1 month / 3 months | −9.4% / −8.8% |
| Return, 1 year / 3 years | +22.2% / +88.0% |
| Trend | Below its 200-day average |
| RSI (14) | 35 |
| Volatility (1 year) | 28.0% |
| Worst drawdown (1 year) | -17.1% |
| Average daily value traded | 13.92M EUR |
| Dividend yield | 2.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Knorr-Bremse is a German manufacturer of braking systems and other safety-critical equipment for rail and commercial vehicles. For rail operators and vehicle builders it supplies braking, door, air conditioning and control systems, while for truck, bus and trailer makers it provides braking systems and driver assistance technology. The company is based in Munich and serves transport manufacturers and fleet operators in markets around the world.
Knorr-Bremse AG trades under the code KBX on the XETRA Stock Exchange in Germany, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Knorr-Bremse AG (KBX) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 95.80 on 23 October 2026.
Its price-based Market X-Ray is 64 out of 100 (a fair price profile), ranking 178 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 22.2% and over the last three months it fell 8.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 52 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -5.7% | ||
| From 52-week high | -17.0% | ||
| Momentum | 54 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -8.8% | ||
| 6-month return | -2.8% | ||
| 12-month return, skipping the last month | 34.9% | ||
| Stability (higher is calmer) | 79 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 28.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -17.1% | ||
| Liquidity | 91 · Strong | Trades actively. | |
| Average daily value traded | 13.92M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 45 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.0% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | −3.7% |
|---|---|
| 1 month | −9.4% |
| 3 months | −8.8% |
| 6 months | −2.8% |
| 1 year | +22.2% |
| 3 years | +88.0% |
| 5 years | +16.5% |
Signals
| 50-day / 200-day average | 102.11 / 101.58 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2.44 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 4 May 2026 | EUR 1.9000 |
| 2 May 2025 | EUR 1.7500 |
| 2 May 2024 | EUR 1.6400 |
| 8 May 2023 | EUR 1.4500 |
| 25 May 2022 | EUR 1.8500 |
| 21 May 2021 | EUR 1.5200 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.